The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 1,461,450 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
JINKOSOLAR HLDG CO LTD | SPONSORED ADR | 47759T100 | 12,148,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
NVIDIA CORPORATION | COM | 67066G104 | 6,524,850 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
TAIWAN SEMICONDUCTOR MFG LTD | SPONSORED ADS | 874039100 | 4,345,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
TAL EDUCATION GROUP | SPONSORED ADS | 874080104 | 65,382,762 | 7,177,032 | SH | SOLE | 7,177,032 | 0 | 0 | ||
YS BIOPHARMA CO LTD | ORDINARY SHARES | G9845F109 | 285,719 | 357,149 | SH | SOLE | 357,149 | 0 | 0 | ||
YS BIOPHARMA CO LTD | *W EXP 03/15/202 | G9845F117 | 20,600 | 500,000 | SH | SOLE | 500,000 | 0 | 0 |